Third View Private Wealth LLC Invests $3.32 Million in MetLife, Inc. $MET

Key Points

• Third View Private Wealth LLC established a new position in MetLife, buying 42,030 shares worth about $3.32 million in Q4, and institutional investors now own roughly 94.99% of the stock.
• Wall Street's consensus rating is a Moderate Buy with an average target of $92.92, though analyst views diverge (e.g., UBS raised its target to $102 while Wells Fargo cut theirs to $90).
• MetLife beat Q4 expectations with $2.49 EPS (vs. $2.34 expected) and reported $52.44 billion in revenue, and analysts forecast about 9.65 EPS for the current fiscal year.

Third View Private Wealth LLC bought a new position in shares of MetLife, Inc. (NYSE:MET - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 42,030 shares of the financial services provider's stock, valued at approximately $3,318,000.

Several other large investors have also made changes to their positions in MET. Brighton Jones LLC raised its stake in shares of MetLife by 9.0% during the 4th quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider's stock worth $347,000 after buying an additional 351 shares during the period. Caxton Associates LLP acquired a new position in shares of MetLife during the 1st quarter worth approximately $307,000. Empowered Funds LLC raised its stake in shares of MetLife by 187.6% during the 1st quarter. Empowered Funds LLC now owns 33,378 shares of the financial services provider's stock worth $2,680,000 after buying an additional 21,771 shares during the period. Sivia Capital Partners LLC acquired a new position in shares of MetLife during the 2nd quarter worth approximately $404,000. Finally, Jump Financial LLC acquired a new position in shares of MetLife during the 2nd quarter worth approximately $444,000. 94.99% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on MET. Keefe, Bruyette & Woods reaffirmed a "moderate buy" rating and set a $87.00 target price on shares of MetLife in a research note on Thursday, March 26th. Wells Fargo & Company reduced their price objective on MetLife from $93.00 to $90.00 and set an "overweight" rating for the company in a research note on Friday. TD Cowen reduced their price objective on MetLife from $91.00 to $88.00 and set a "buy" rating for the company in a research note on Wednesday, March 11th. Morgan Stanley reduced their price objective on MetLife from $101.00 to $93.00 and set an "overweight" rating for the company in a research note on Tuesday, March 3rd. Finally, Evercore set a $96.00 price objective on MetLife in a research note on Thursday. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, MetLife presently has an average rating of "Moderate Buy" and an average target price of $92.92.

Key MetLife News

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: UBS raised its price target on MET to $102, signaling greater analyst optimism about earnings power and valuation upside. UBS raises price target
• Positive Sentiment: MetLife Foundation announced over $6.5M in global grants to address community needs — a positive ESG/brand item that can support reputation and stakeholder goodwill. MetLife Foundation grants
• Neutral Sentiment: Coverage-piece on MetLife’s deal with PineBridge and a push into private credit — this strategic shift could boost investment yields and recurring income but also raises illiquidity and credit-risk considerations for investors. PineBridge & private credit analysis
• Neutral Sentiment: MetLife Stadium will temporarily be renamed (e.g., “New York New Jersey Stadium”) for the FIFA World Cup due to FIFA sponsorship rules — a short-term reduction in visible MetLife branding during a high-profile event; PR impact is limited and temporary. Stadium name change explanation
• Neutral Sentiment: Local transit plans for the World Cup (partial Penn Station closures and commuter discounts) add event logistics uncertainty that could affect attendance patterns around stadium events but are unlikely to materially affect MetLife’s financials. Commuter discounts for Penn Station closure
• Negative Sentiment: Wells Fargo cut its MET price target to $90, introducing a bearish analyst view that could cap near-term upside and pressure sentiment among institutional holders. Wells Fargo cuts price target

MetLife Trading Up 2.1%

MET opened at $75.42 on Tuesday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.20 and a quick ratio of 0.20. The company's 50 day simple moving average is $73.10 and its two-hundred day simple moving average is $76.91. MetLife, Inc. has a 1-year low of $67.33 and a 1-year high of $83.85. The firm has a market capitalization of $49.18 billion, a price-to-earnings ratio of 16.05, a price-to-earnings-growth ratio of 0.66 and a beta of 0.74.

MetLife (NYSE:MET - Get Free Report) last released its earnings results on Wednesday, February 4th. The financial services provider reported $2.49 earnings per share for the quarter, topping analysts' consensus estimates of $2.34 by $0.15. MetLife had a net margin of 4.38% and a return on equity of 21.81%. The business had revenue of $52.44 billion for the quarter, compared to analyst estimates of $31.43 billion. During the same period last year, the company posted $2.08 EPS. The business's revenue was up 27.6% on a year-over-year basis. Analysts expect that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.